Evidence map›Paper›PMID 17245432›Full record

ArticleThe EMBO journal2007

Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency.

Isaure du Chéné, Euguenia Basyuk, Yea-Lih Lin, Robinson Triboulet, Anna Knezevich, Christine Chable-Bessia, Clement Mettling, Vincent Baillat, Jacques Reynes, Pierre Corbeau and 5 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02707900 (IGHID 11424 - A Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection), which is not on this map. Cited by 208 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
208citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02707900 phase1terminatednot on this mapstarted 2016, after this paper: background citation

IGHID 11424 - A Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection (The VOR VAX Study)

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2016 to 2018Enrolled6ConditionsHIV-1 InfectionArmsVorinostat, AGS-004
3 · Its place in the literature

Who cites it

208 citing papers in PubMed, 1 synthesis or guideline pooled it, 307 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Latency Reversing Agents and the Road to an HIV CurePathogens (Basel, Switzerland) · 2025
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

148 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Isaure du ChénéLaboratoire de Virologie Moléculaire, Institut de Génétique Humaine, UPR 1142, Montpellier, France.
Euguenia Basyuk
Yea-Lih Lin
Robinson Triboulet
Anna Knezevich
Christine Chable-Bessia
Clement Mettling
Vincent Baillat
Jacques Reynes
Pierre Corbeau
Edouard Bertrand
Alessandro Marcello
Stephane Emiliani
Rosemary Kiernan
Monsef Benkirane
Institut de Génétique Moléculaire de Montpellier · FRInstitut de Génétique Humaine · FRHôpital Gui de Chauliac · FRInternational Centre for Genetic Engineering and Biotechnology · ITInstitut Cochin · FRInstitut de Génomique Fonctionnelle · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HIV-1 gene expression is the major determinant regulating the rate of virus replication and, consequently, AIDS progression. Following primary infection, most infected cells produce virus. However, a small population becomes latently infected and constitutes the viral reservoir. This stable viral reservoir seriously challenges the hope of complete viral eradication. Viewed in this context, it is critical to define the molecular mechanisms involved in the establishment of transcriptional latency and the reactivation of viral expression. We show that Suv39H1, HP1gamma and histone H3Lys9 trimethylation play a major role in chromatin-mediated repression of integrated HIV-1 gene expression. Suv39H1, HP1gamma and histone H3Lys9 trimethylation are reversibly associated with HIV-1 in a transcription-dependent manner. Finally, we show in different cellular models, including PBMCs from HIV-1-infected donors, that HIV-1 reactivation could be achieved after HP1gamma RNA interference.

Indexed as

Gene SilencingVirus IntegrationVirus LatencyCell Cycle ProteinsCells, CulturedChromatinChromosomal Proteins, Non-HistoneHeLa CellsHistone AcetyltransferasesHistone-Lysine N-MethyltransferaseHistone MethyltransferasesHistonesHIV-1HIV Long Terminal RepeatHumansJurkat CellsCBX3 protein, humanCell Cycle ProteinsChromatinChromosomal Proteins, Non-HistoneHistone AcetyltransferasesHistone-Lysine N-MethyltransferaseHistone MethyltransferasesHistonesMethyltransferasesp300-CBP-Associated Factorp300-CBP Transcription FactorsPositive Transcriptional Elongation Factor BProtein MethyltransferasesRepressor ProteinsSp1 Transcription FactorSUV39H1 protein, humanTranscription Factors

Identifiers

PMID17245432
PMCPMC1783455
OpenAlexW2049874714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.